Why Proteostasis Shares Are Exploding
Proteostasis Therapeutics shares absolutely exploded in Tuesday’s session, more than doubling after the firm reported positive study results.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 150
Short Sellers Can’t Make Up Their Minds on Major Pharma
The November 30 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks was mixed.
Major Biotechs See Rising Tide in Short Interest
The November 30 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Will Consumers Trust Generic Viagra?
A generic version of Viagra is coming to America, but will existing customers be willing to switch over to a generic version of the pill?
Blueprint Medicines Wins Big in Early-Stage Trial
Blueprint Medicines watched its shares make a solid gain on Monday morning after the firm announced results for its ongoing early-stage trial for advanced systemic mastocytosis.
4 Large Cap Biotech Leaders Are Huge Tax Reform Winners
One industry that could be a huge winner from tax reform, and may surprise some investors, is biotechnology, especially for the large cap leaders in the group.
Denali Therapeutics Enters the Market With a Bang
Denali Therapeutics entered the markets with a bang on Friday. In its initial public offering, the company priced its almost 14 million shares within the expected range.
Radius Health Breast Cancer Trial Continues to Show Progress
Radius Health shares climbed higher on Friday after the firm provided an update on its early-stage clinical study in patients with estrogen receptor positive breast cancer.
Americans Favor Government-Mandated Health Care Again: Gallup
More than half of Americans now believe that government has a responsibility to make sure that all Americans have health care coverage.
Is This the Turnaround SteadyMed Has Waited For?
SteadyMed saw its shares make an incredibly gain to close out the week, after a positive meeting with the FDA.
Will Alexion Pharmaceuticals Fight This Activist?
Alexion Pharmaceuticals shares saw a handy gain early on Friday after the New York Times reported that there might be some increasing activist movement in the stock.
Could Sage Therapeutics’ Depression Drug Be the Next Big Thing?
Sage Therapeutics saw its shares make an incredible gain on Thursday after the firm announced positive top-line results from its midstage trial.
Arrowhead Pharma Wins in Midstage Hepatitis Study
Arrowhead Pharmaceuticals saw its shares make a handy gain on Wednesday after the firm presented new data from its midstage study for the treatment of hepatitis B infection.
How a Key Health Care Merger May Play a Role in Warren Buffett’s Investing
DaVita has long been considered a takeover target, with a twist involving Warren Buffett. How will analysts value DaVita in the future?
2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors
It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately, most of these are currently projected to deliver a solid 2018.